Suchergebnisse - "Shimozaki, Keitaro"

PubPharm (43)

1

Pre-existing Interstitial Lung Abnormalities and Immune Checkpoint Inhibitor-Related Pneumonitis in Solid Tumors : A Retrospective Analysis

enthalten in: The oncologist | 2024

von Horiuchi, K. | Ikemura, S. | Sato, T. | +17

2

Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab as Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer : A Single-Institution Retrospective Study

enthalten in: Journal of gastric cancer | 2023

von Shimozaki, K. | Nakayama, I. | Takahari, D. | +11

3

Current Strategy to Treat Immunogenic Gastrointestinal Cancers : Perspectives for a New Era

enthalten in: Cells | 2023

von Shimozaki, K. | Nakayama, I. | Hirota, T. | +1

4

KRAS mutation as a predictor of insufficient trastuzumab efficacy and poor prognosis in HER2-positive advanced gastric cancer

enthalten in: Journal of cancer research and clinical oncology | 2023

von Shimozaki, K. | Shinozaki, E. | Yamamoto, N. | +10

5

Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer

enthalten in: International journal of clinical oncology | 2023

von Kamiimabeppu, D. | Wakatsuki, T. | Takahari, D. | +9

6

Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer : a multicenter retrospective study in Japan

enthalten in: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association | 2023

von Aoki, M. | Kadowaki, S. | Takahashi, N. | +24

7

Severe drug eruption after antibiotic administration in patients receiving immune checkpoint inhibitors : A monocentric case series

enthalten in: JEADV Clinical Practice | 2023

von Nishizawa, A. | Takeda, K. | Urasaki, T. | +14

8

Clinical Usefulness of Postoperative Serum Carcinoembryonic Antigen in Patients with Colorectal Cancer with Liver Metastases

enthalten in: Annals of surgical oncology | 2022

von Yoshino, K. | Osumi, H. | Ito, H. | +15

CommentIn: Ann Surg Oncol. 2022 Dec;29(13):8394-8395. - PMID 35933537

9

WJOG13219G : The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)

enthalten in: Clinical colorectal cancer | 2022

von Shimozaki, K. | Hirata, K. | Sato, T. | +17

10

Treatment efficacy of ramucirumab-containing chemotherapy in patients with alpha-fetoprotein producing gastric cancer

enthalten in: International journal of clinical oncology | 2022

von Kamiimabeppu, D. | Wakatsuki, T. | Takahari, D. | +9

1
2
3
4
5
Nächster »
[5]